Your COVID-19 immunity could last 'possibly a lifetime'
Two new studies suggest COVID-19 immunity following infection could last a year, or "possibly a lifetime, improving over time especially following vaccination" The New York Times reported on Wednesday, hopefully allaying "lingering fears that protection against the virus will be short-lived."
When taken together, the studies suggest most (but not all) vaccinated individuals who were previously infected with COVID-19 "will not need boosters," wrote the Times. Those who were vaccinated without having previously contracted the virus will likely need the extra dose. Experts expect immunity in these individuals to "play out very differently," as "immune memory" may look different following vaccination compared to natural infection.
"The papers are consistent with the growing body of literature that suggests that immunity elicited by infection and vaccination for SARS-CoV-2 appears to be long-lived," said Scott Hensley, an immunologist not involved in the studies. Dr. Michel Nussenzweig, a researcher for one of the studies, added he expects antibodies in those who were previously infected and later vaccinated to "last for a long time."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Results, however, also underscore the idea that previous infection is not enough to protect individuals long-term on its own — even those who have recovered should be vaccinated, wrote the Times. Read more at The New York Times.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
The best books of 2024 to give this Christmas
The Week Recommends From Percival Everett to Rachel Clarke these are the critics' favourite books from 2024
By The Week UK Published
-
Parmigianino: The Vision of St Jerome – masterpiece given 'new lease of life'
The Week Recommends 'Spectacularly inventive' painting is back on display at the National Gallery
By The Week UK Published
-
5 unidentifiable cartoons about drones over New Jersey
Cartoons Artists take on national priorities, national security, and more
By The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published